AGC Biologics, a global therapeutic protein production company, announced yesterday that it has named Christopher Holt as Site Head/General Manager of its Bothell, Washington operations.
Holt will offer leadership and site management overseeing delivery of contract development and manufacturing services.
Holt has more than 20 years of leadership experience in the biotechnology and manufacturing industry, having worked for Lonza, DSM/Patheon and GlaxoSmithKline in the US and Europe.
EDX Medical to provide molecular profiling services to Astron Health
Futura Medical appoints Market Performance Group as new US distribution partner for Eroxon
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
Sensei Biotherapeutics changes name to Faeth Therapeutics
Datavault AI and Wellgistics Health plan DelivMeds AI healthcare venture
Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award
Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning
Atrium Therapeutics announces inducement grants to seven new employees